Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

43 Results Found

CDC investigating counterfeit, mishandled botulinum toxin injections

The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received botulinum toxin injections that were counterfeit or administered in non-healthcare settings or by unlicensed or untrained individuals.
Public

Henry Ford Health: Accelerating Efforts to Reduce CLABSI Rates Yields Promising Results

Henry Ford’s hematology-oncology unit has reduced the incidence of CLABSIs in its hematology-oncology unit by 75%, documenting only two cases between July 2020 and June 2021.

Infection Control and Prevention

Healthcare-Associated Infections (HAI) prevention and reduction are longstanding quality and patient safety priorities.

A Chief Medical Officer's Success Story for Physician Engagement, Referral Development, and Wellbeing

Presentation Resource
TMCA went from the 50th percentile to Top 10 nationally in terms of physician engagement and alignment, with double digit increases on the satisfaction survey, physician turnover decreased by 5%, with first year physician turnover cut in half, and quality improved with a significant decline in Hospital Acquired Infection. TMCA saw measurable results on decreasing referral leakage, improving referral development, and gaining access for their Physician Relations Manager (PRM) team to meet with key physicians.

What Is a CLABSI and How to Prevent It

In this episode of the Advancing Health podcast series, Nishant Prasad, M.D., attending physician and program director of infectious diseases at NewYork-Presbyterian Queens, shares how they re-approached CLABSI prevention by deeply examining structure and process, and how their work got them to zero CLABSIs in the last year.